The British Society for Sexual Medicine (BSSM) was founded in 1997 (as the British Society for Sexual and Impotence Research, or BSSIR) to promote research and exchange of knowledge across the UK scientific community.
Testosterone deficiency is increasingly common and has significant health implications, but it can be challenging to diagnose and treat. Here the authors present a summary of a recent update to the British Society for Sexual Medicine (BSSM) guidelines on male adult testosterone deficiency…
The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice
One of the most consistently identified predictors of impaired sexual health in women is the presence of vaginal symptoms. The vast majority of postmenopausal women have symptoms associated with Genitourinary Syndrome of the Menopause (GSM) …
Several age-related conditions are associated with increased rates of hypogonadism, notably, T2DM, obesity, CHD, Heart failure, CKD, COPD, HIV, and men on long term opiates.
Testicular cancer (TC) is the most common malignancy in young men, with around 18 000 new diagnoses in Europe each year. While this disease often used to have a lethal outcome, with the main aim being to increase the chance of survival, improved treatments…
Background: This is an update of the 2008 British Society for Sexual Medicine (BSSM) guidelines. Aim: To provide up-to-date guidance for U.K. (and international) health care professionals managing male sexual dysfunction.
Based on the 2017 British Society for Sexual Medicine (BSSM) guidelines on adult testosterone deficiency, with statements for UK practice
British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice
T is the principal androgen in men. It is essential for the development and maintenance of secondary male characteristics.3 When T levels decrease, patients can experience physical and psychological effects, which can compromise their general wellbeing, sexuality, and fertility.
Graham Jackson introduced the concept that erectile dysfunction was a marker for undiagnosed cardiovascular disease and future events. Unfortunately this had had modest impact on CVD management as ED is not incorporated into current risk calculators. In this paper, we examine recent evidence as to whether ED should be upgraded to a risk factor, especially with the high predictive value in younger men.
Background: Testosterone deficiency (TD) is an increasingly common problem with significant health implications, but its diagnosis and management can be challenging. Aim: To review the available literature on TD and provide evidence-based statements for UK clinical practice.
- Medical: https://sexualadviceassociation.co.uk/
- Patient App: https://sexualadviceassociation.co.uk/app/
- PCTAG: http://www.pctag.uk/
- Testosterone calculator: http://www.pctag.uk/testosterone-calculator/
- TCalc App: Google Play store: https://play.google.com/store/apps/details?id=com.app.tcalc&gl=US&pli=1